My email. To Whom it May Concern: I am writing as a

New Post Public Reply Private Reply Replies (1) Message Board
Courtjester
My email.

To Whom it May Concern:

I am writing as a concerned shareholder of CEN Biotech/ FITX. Many of us shareholders believe there is a concerted media attack against the company and it's stock FITX. I am aware that there have already been emails about the issues with Lakeshore, the attack pieces from the Globe and Mail, Windsor Star, etc. So, to avoid repetition, I am going to focus this email on a different matter.

There are three major stock message boards that have a page dedicated to FITX. The three are: Yahoo, iHub, and Investor's Hangout. On Yahoo and iHub, free-rein bashing is allowed on our company. When I say "bashing," I am not merely talking about disagreement with the company or concern about the direction the management is taking it. I am talking about truly concerning, possibly illegal activity.

First of all, these boards seem to be used to manipulate the price per share of the stock by people outside of the company. For awhile, investors may be able to have good discussions about our stock on the boards. Then, suddenly, a swarm of screen names appear, and the topics are: "This company is a scam!" "Pump and dump," "You people are stupid to keep this stock," "Bill Chaaban is going to jail," and on and on. This is very discouraging to us, if not for the presence of the actual share holders during a bash cycle, the only things the public would see on these boards would be negative. We should not have to defend our investment on a board designed for stock holders. Some of these bashers are "professional" bashers. They post 24 hours a day, round the clock in shifts, and in my opinion are being paid for their services.

After the share prices have dropped, all of a sudden the bashers quiet down, and then a whole bunch of new screen names that we don't recognize pop up screaming that FITX is the greatest stock EVER! "It's going to $1 in the next two weeks!" "Bill Chaaban is AWESOME!" "Buy! Buy! Buy!" Even though we shareholders like to hear things like that, we know true "pumpers" when we see them! It's very disconcerting. Then after the pps has come up a couple of cents, just as suddenly, the pps plummets. because the bashers come back. Obviously the bashers help bring the stock down so it may be bought at the lowest possible price, then pumped back up so it can be sold at a profit, then rinse and repeat.The last time this cycle occurred was just before an article from the Globe and Mail was released, (Feb 13) and the timing of this seems very suspicious to me. It had almost doubled in two days, then lost 3/4 of it's value on the next trading day. t's truly maddening, because us REAL shareholders are helpless to stop the cycle!

If that's not bad enough, some of the tactics the bashers use on the boards are reprehensible. There have been posts that are obscene, posts that are racist, and some that have been downright threatening. Some bashers have gone as far to find the name, address, and family information of some of our shareholders, and regularly post this info, along with assorted obscenities. These types of issues are becoming safety concerns for us shareholders.

I feel the company management is honest and I have never felt misled. I never invested in this to become wealthy overnight. Anybody who invests in a REAL company expecting to become an instant millionaire is sure to be disappointed. There are no guarantees in the markets. But, just because a company has difficulties does NOT make it a bad investment, even more especially when there seems to be a multi-source attack on it. This may be a "Pink Sheet" penny stock, but the volatility of the share prices have nothing to do with the company management, and everything to do with outside influences.

Thank you for your time.

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 6

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading

Top 5 Most Recently Viewed Articles

PMGC Capital's Strategic Investment in Alaunos Therapeutics

Updated Category News Views 171

PMGC Capital LLC Plans to File Schedule 13D on Alaunos PMGC Capital LLC, a fully owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), has made a significant move in the financial landscape by announcing its intention to file a Schedule 13D with the U.S. Securities and Exchange Commission (SEC). This filing will disclose its beneficial ownership in Alaunos Therapeutics,...

Continue Reading
Black Diamond Therapeutics: Pivotal Developments Ahead

Updated Category News Views 97

Black Diamond Therapeutics Continues to Make Strides Recently, H.C. Wainwright confirmed a Buy rating on Black Diamond Therapeutics (NASDAQ: BDTX) shares, projecting a price target of $11.00. This positive outlook follows the company's major restructuring efforts aimed at advancing BDTX-1535, its leading drug candidate, into pivotal trials. This move is expected to not...

Continue Reading
Eureka Acquisition Corp Announces New Meeting Date and Deadlines

Updated Category News Views 187

Eureka Acquisition Corp's Important Announcement New York — Eureka Acquisition Corp (NASDAQ: EURK), a special purpose acquisition company, has recently made significant announcements regarding the schedule of its extraordinary general meeting. Originally set for June 20, it will now take place on June 25, providing shareholders with extra time for participation. Details...

Continue Reading
Diamedica Therapeutics Hits New Heights with $6.41 Stock Value

Updated Category News Views 118

Diamedica Therapeutics Inc. Achieves 52-Week High Diamedica Therapeutics Inc. (NASDAQ: DMAC) is making headlines as its stock has recently hit a remarkable 52-week high of $6.41. This impressive milestone comes amid a significant growth phase for the company, which is currently valued at around $230 million. The steep rise in the stock price over the past year indicates a...

Continue Reading
J.P. Morgan's Projections for 2025: Capital Market Insights

Updated Category News Views 6083

J.P. Morgan's Capital Market Assumptions for 2025 J.P. Morgan Asset Management has recently unveiled its 2025 Long-Term Capital Market Assumptions (LTCMAs), providing valuable insights into the anticipated returns and risks across various asset classes for the next decade. These projections serve as a compass for investment strategies, targeting institutional and...

Continue Reading